Shares of Medifast (MED) continue to do well. Since I first recommended the stock in my Emerging Growth service in July, the stock has tripled. The latest reason for the surge is a recall from revival Slim Fast.
Unilever PLC’s U.S. subsidiary says it has recalled all canned Slim Fast drinks because of the possibility of bacterial contamination that could cause diarrhea, nausea and vomiting.
Yikes! What’s bad for Slim Fast is good for Medifast. I’ve added Medifast to my Top 5 for the month of December.